RIS Rx Welcomes Industry Pioneer Tom Doyle as Senior Advisor [Yahoo! Finance]
Cencora, Inc. (COR)
Last cencora, inc. earnings: 4/30 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.coresite.com/investor-overview
Company Research
Source: Yahoo! Finance
IRVINE, Calif., April 23, 2026 BUSINESS WIRE )--RIS Rx, the healthcare technology company delivering real-time GTN Revenue Protection for the world's leading pharmaceutical manufacturers, today announced that Tom Doyle has joined the organization as Senior Advisor. Doyle, a widely respected executive with decades of leadership across pharmaceutical distribution, services, and outsourced commercialization, will provide strategic guidance as RIS Rx continues to expand its footprint across the industry. Tom brings an extraordinary track record to his new role. He spent several years at Cencora Biopharma Services in senior executive leadership, including serving as SVP and Chief Customer Officer. Throughout his tenure, he led teams focused on integrating the full spectrum of Cencora's global capabilities to enhance patient outcomes. Prior to Cencora, he served as SVP of Program Leadership at EVERSANA, spearheading the launch of outsourced commercialization services and overseeing a tea
Show less
Read more
Impact Snapshot
Event Time:
COR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COR alerts
High impacting Cencora, Inc. news events
Weekly update
A roundup of the hottest topics
COR
News
- Cencora (COR) is now covered by William Blair. They set a "market perform" rating on the stock.MarketBeat
- Vesey Street Capital Partners Strengthens its Team by Announcing Kurt Hilzinger as Vice Chairman of its Strategic Advisory Board [Yahoo! Finance]Yahoo! Finance
- CareMetx Acquires U.S.-based Patient Services and Free Goods Pharmacy Operations from Cencora, Significantly Expanding Its Patient Access Platform [Yahoo! Finance]Yahoo! Finance
- Maryland Supreme Court tosses Baltimore's $152 million opioid lawsuit win [CBS News]CBS News
- Cencora, Inc. (COR) Expands Into Retina Services Business in $1.1B Deal [Yahoo! Finance]Yahoo! Finance
COR
Earnings
- 2/4/26 - Beat
COR
Sec Filings
- 4/29/26 - Form SCHEDULE
- 4/2/26 - Form 4
- 3/26/26 - Form SCHEDULE
- COR's page on the SEC website